Sublingual Immunotherapy: How Allergy Drops and Tablets Work

Sublingual immunotherapy (SLIT) is allergy treatment taken under the tongue instead of through injections. You hold a small, regular dose of the allergen, as a tablet or a liquid drop, in your mouth, and over months and years your immune system learns to tolerate it. Cleveland Clinic describes SLIT as exposing the immune system to small amounts of allergen so that, with regular treatment, allergic symptoms can ease. It works best for a defined set of respiratory allergies, it takes years rather than weeks, and it needs a specialist to select and monitor it.
TL;DR
SLIT is daily under-the-tongue allergen immunotherapy, as a tablet or drops. It aims to build tolerance, not just mask symptoms.
The strongest evidence is for grass pollen and house dust mite. Evidence for pet dander is much thinner.
Many people notice a change within months, but treatment usually runs about three years or longer.
Compared with allergy shots, SLIT avoids needles and routine injection visits, and severe systemic reactions are less common. It does depend on you taking every dose at home.
U.S. insurance coverage varies a great deal by plan. Ask your insurer before you start.
Table of Contents
What sublingual immunotherapy is and how it works
Allergy medicines such as antihistamines and nasal sprays manage symptoms while you take them. Immunotherapy does something different: it changes how your immune system responds to the trigger. In SLIT, a measured dose of allergen is placed under the tongue, where the lining of the mouth exposes your immune cells to it in a controlled way.
The 2026 World Allergy Organization position paper describes SLIT as allergen immunotherapy delivered under the tongue. It reports expert consensus that exposure through the oral mucosa promotes allergen-specific immune tolerance rather than simply masking symptoms. That distinction is why treatment is continued for years: the goal is a lasting shift in response.

Tablets versus drops
SLIT comes in two forms, and they are not regulated the same way in the United States.
Tablets are FDA-approved products for specific allergens. According to the American College of Allergy, Asthma and Immunology, U.S. SLIT tablets cover dust mite, Timothy grass, grass pollen and short ragweed.
Drops are liquid extracts prepared for the individual patient. The same ACAAI guide notes that allergy drops are not FDA-approved and are used off-label.
That difference matters when you compare options. A tablet is a single standardized product with its own trial data. Drops are mixed by a clinician, so the evidence has to be read product by product. The German-Austrian-Swiss allergy societies caution that concentrations from different manufacturers cannot be compared meaningfully and that efficacy should not automatically be carried over from one product to another.
Who SLIT is for
SLIT is used for respiratory allergies: hay fever (allergic rhinitis) and, in some patients, allergic asthma linked to a confirmed trigger. It is not a treatment for food allergy or for general “sensitivities” found on an unvalidated test. The first step is always confirming that you are truly sensitized to the allergen you want to treat.
The ASCIA guide for specialists lists confirmed sensitization, and the patient’s willingness to complete at least three years, among the factors that should shape the choice of route. Cost, convenience and accessibility belong on the same list.
If you are unsure what your tests actually show, our guides on IgG versus IgE antibody testing and food sensitivity testing explain why only IgE-based results, interpreted alongside your history, support an allergy diagnosis.
SLIT often suits people who:
are allergic to one or a few well-defined triggers, such as grass pollen or dust mites
want to avoid needles or frequent clinic visits
can commit to a daily routine for years
are ready to work with a clinician on follow-up
Do allergy drops and tablets work?
For the right allergens, yes. A 2018 systematic review of 112 randomized trials concluded that well-controlled studies generally support SLIT efficacy in children and adults with respiratory allergy during the first three years of treatment. The same review found the evidence strongest for grass pollen and house dust mite, with effects varying by product and allergen.
A 2026 review in Frontiers in Allergy reported robust randomized-trial evidence for meaningful reductions in symptoms and medication use with grass-pollen and house-dust-mite SLIT tablets. In key trials, benefit lasted up to one or two years after three years of treatment. The authors also note that trials differ enough that evaluating a specific product is more reliable than making broad claims about all SLIT.

Pet allergies are a different story
People often ask whether SLIT can treat cat or dog allergy. The honest answer is that the evidence is limited. The German-Austrian-Swiss guideline describes animal-dander immunotherapy, mainly for cat allergen, as resting on small studies, some with methodological weaknesses. A review of cat-allergen immunotherapy found mixed results for both shots and drops, and concluded that some carefully selected patients may benefit while larger trials are needed. If pet allergy is your main concern, a specialist can help you weigh that evidence against your symptoms.
How long until you notice a difference
Expect gradual change. Johns Hopkins Medicine reports that many patients notice improvement from daily drops after roughly three to four months, with treatment commonly continuing for three to five years. The 2018 systematic review says improvement may begin in the first month for some people.
As for when to judge it, the ASCIA guide recommends assessing efficacy after six to twelve months for year-round allergens, or after two pollen seasons. If the treatment is helping, it may continue for three years. The 2026 World Allergy Organization update reached 98.3% consensus that SLIT should generally be prescribed for at least three years and considered potentially disease-modifying.
A practical timeline looks like this:
Before starting: confirm the allergen with testing and a clinical history.
First dose: taken under observation in a medical setting.
First weeks: daily home dosing, with mild mouth symptoms that often settle.
Months 3 to 12: the first check on whether symptoms and medication use are falling.
Years 1 to 3 and beyond: continued daily dosing with structured follow-up.
Side effects and safety
Most side effects are local and mild. The ASCIA guide lists oral itching, throat discomfort, minor swelling under the tongue and salivary-gland discomfort as the common ones. Gastrointestinal symptoms are uncommon, and itching often settles after four to six weeks. The systematic review found that most treatment-related events occur in the first weeks, and about 5% of trial participants stopped because of them.
The World Allergy Organization panel judged adverse events generally mild and self-limited. It considered systemic reactions rare and typically not life-threatening.
Safe use
Take the first dose under supervision. Cleveland Clinic states that the first dose is generally given in the provider’s office for observation, with later doses at home.
Keep prescribed epinephrine available. Cleveland Clinic notes that an auto-injector is prescribed because serious reactions, although rare, can occur. Ask your prescriber how and when to use it.
Pause when told to. The WAO paper says treatment should be avoided or paused as directed for uncontrolled asthma, significant oral inflammation or injury, febrile illness, and other product-specific contraindications. If you have asthma, tell your prescriber before starting and call if your control worsens.
Follow your product’s instructions exactly, including how long to hold the dose under the tongue.
SLIT vs SCIT: allergy drops compared with allergy shots
Subcutaneous immunotherapy (SCIT) is the classic allergy shot, given in a clinic. Both routes aim at the same immune tolerance. They differ in logistics and in risk profile.
Factor | SLIT (drops or tablets) | SCIT (allergy shots) |
How it is given | Daily under the tongue, at home | Injections in a clinic, then observation |
Needles | None | Yes |
First dose | Usually observed in the office | Every injection is observed |
Common reactions | Mouth and throat itching, mild swelling | Local reactions at the injection site |
Severe systemic reactions | Less frequent | More frequent |
Biggest practical risk | Missed doses at home | Missed clinic visits |
Allergens covered | Narrower, strongest evidence for grass and dust mite | Broader range of allergens |
The ASCIA guide summarizes the trade-off this way: SLIT avoids needles and routine injection visits but requires reliable daily home adherence. SCIT requires clinic injections and observation, but it gives a more standardized, physician-administered schedule. The German-Austrian-Swiss guideline says systemic reactions occur far less often with SLIT than with SCIT, giving SLIT a better safety profile for anaphylaxis and other severe reactions.
Adherence deserves honest attention. The same guideline identifies it as vital to success and notes that real-world adherence is lower than clinicians often assume, for both routes. Choose the one you will actually keep up for three years. Someone who travels constantly may prefer drops. Someone who knows they forget daily routines may do better with a scheduled clinic visit.
Questions to ask when choosing
Which allergens are confirmed by testing, and which have good evidence for each route?
Is a standardized tablet available for my trigger, or would I use custom drops?
How will my first dose and follow-up be handled?
What will I pay, and what will my plan cover?
What SLIT costs and whether insurance covers it
There is no single price, and we will not guess one. What you pay depends on the form, the allergens, your plan and the clinic. Coverage is where the real differences show up.
A U.S. insurer’s medical policy states that FDA-approved SLIT tablets are generally covered under the pharmacy benefit when medically appropriate, while coverage depends on the specific contract.
A university health plan policy states that the plan does not cover SLIT for any condition, because it considers the treatment unproven or investigational under that policy.
Those two examples show how far plans can differ. Because drops are off-label in the U.S., they are the form most likely to be paid out of pocket. Before you start, call your insurer and ask three things: whether SLIT tablets are on your pharmacy formulary, whether drops are covered at all, and whether visits for testing and follow-up are covered separately. Ask any clinic for a written estimate that includes testing, the first supervised dose and follow-up visits.
Where we stand
At Green Circle Wellness we treat allergy as a root-cause question, not just a symptom list. Immunotherapy fits that thinking because it aims to retrain the immune response instead of covering it up. What we value most in SLIT is what it asks of both sides: time and structure. Our patient-centered approach gives you ample time with practitioners to talk through which triggers matter, what testing shows, and which treatment route you can realistically sustain. A multidisciplinary team can then fold allergy care into the rest of your health picture, including gut health, nutrition and immune function. We would rather build a plan around your confirmed triggers and your daily life than hand you a one-size-fits-all protocol. Drops, tablets and shots are tools. The right one is the one that is supported by evidence for your allergen and that you will keep using. Dina
Getting started with allergy care in Chicago
If you are in Chicago, or in Illinois and open to a virtual consultation, our team can start with your history and the testing that actually identifies your triggers, then discuss the options for your situation. Our Advanced Allergy Therapy page explains how we approach allergy care, and you can see our full range of integrative services too.

If allergies are one piece of a bigger picture, such as chronic inflammation, gut issues or an autoimmune condition, our functional medicine team can look at them together. Prices are not published online, so contact us for details when you book.
FAQ
Do SLIT allergy drops really work?
For respiratory allergies, especially grass pollen and house dust mite, trial evidence supports SLIT. A 2018 review of 112 randomized trials found generally good support during the first three years of treatment. Results vary by product and allergen, so ask which evidence applies to yours.
Is SLIT the same as allergy shots?
No. Both are allergen immunotherapy, but SLIT is taken under the tongue at home, while shots are given by injection in a clinic. The guidelines cited above report that severe systemic reactions are less frequent with SLIT, while shots offer a more supervised schedule.
How long do you take sublingual immunotherapy?
Usually about three years at minimum, and commonly three to five. Some people notice improvement in the first months. Your clinician will usually review progress after six to twelve months, or after two pollen seasons.
Is there immunotherapy for pet allergies?
Individual formulations may be prescribed for animal allergens, but the evidence, mostly for cats, comes from small studies with mixed results. Some carefully selected patients may benefit. Talk with an allergy specialist about whether it makes sense for you.
Does insurance cover sublingual immunotherapy?
It depends on your plan. Some insurers cover FDA-approved SLIT tablets through the pharmacy benefit, while others exclude SLIT entirely. Allergy drops are off-label in the U.S., so confirm coverage with your insurer before you begin.
Sources
Sublingual Immunotherapy (SLIT): Treatment & Results, Cleveland Clinic
World Allergy Organization Sublingual Immunotherapy position paper, 2026
Sublingual allergen immunotherapy for respiratory allergy: a systematic review, 2018
Sublingual allergen immunotherapy: evidence review, Frontiers in Allergy, 2026
Sublingual Immunotherapy - Allergy Drops, Johns Hopkins Medicine
Guideline on allergen-specific immunotherapy (Germany, Austria, Switzerland)
Does evidence support the use of cat allergen immunotherapy?
Recommended
This article is for education only and is not medical advice.



Comments